The deadly risks of TAVR being downplayed to patients by hospitals

January 18, 2015- By Steven E. Greer, MD

On July 20th, 2011, the FDA convened an advisory committee to help it determine whether to approve the first ever TAVR device called the Sapien, made by Edwards Lifesciences. I was a public speaker raising the Read more »

Christopher Anderson, MD: Deep brain stimulation for epilepsy

Christopher Anderson, MD, neurologist and epilepsy specialist from the University of Pennsylvania, discusses the new data from the SANTE trial that evaluated deep brain stimulation (DBS) for the treatment of medically refractory seizures. The FDA will be convening an advisory committee on March 12^th to decide whether to approved this new indication for DBS.